Table of Content



1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Pulmonary Arterial Hypertension Market – By Drugs
1.3.2 MEA Pulmonary Arterial Hypertension Market – By Type
1.3.3 MEA Pulmonary Arterial Hypertension Market – By Route of Administration
1.3.4 MEA Pulmonary Arterial Hypertension Market – By Distribution Channel
1.3.5 MEA Pulmonary Arterial Hypertension Market – By Country

2. MEA Pulmonary Arterial Hypertension Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Pulmonary Arterial Hypertension Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion

5. MEA Pulmonary Arterial Hypertension Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Incidence of Pulmonary Arterial Hypertension
5.2 Market Restraints
5.2.1 Side Effects of Drugs Used for Treatment of Pulmonary Arterial Hypertension
5.3 Market Opportunities
5.3.1 Availability of Generics at Affordable Costs Due to Growing Patent Expiration
5.4 Future Trend
5.4.1 Rising Clinical Trials for Drugs Development to Treat Pulmonary Arterial Hypertension
5.5 Impact analysis

6. Pulmonary Arterial Hypertension Market – MEA Analysis
6.1 MEA Pulmonary Arterial Hypertension Market Revenue Forecast and Analysis

7. MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Drugs
7.1 Overview
7.2 MEA Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)
7.3 Endothelin Receptor Antagonists (ERAs)
7.3.1 Overview
7.3.2 Endothelin Receptor Antagonists (ERAs): MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Prostacyclin and Prostacyclin Analogs
7.4.1 Overview
7.4.2 Prostacyclin and Prostacyclin Analogs: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
7.5 SGC Stimulators
7.5.1 Overview
7.5.2 sGC Stimulators: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pde-5 Dipsticks
7.6.1 Overview
7.6.2 Pde-5 Dipsticks: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Pulmonary Arterial Hypertension Market Analysis and Forecasts to 2028 – by Type
8.1 Overview
8.2 MEA Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Generics
8.4.1 Overview
8.4.2 Generics: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Route of Administration
9.1 Overview
9.2 MEA Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)
9.3 Oral
9.3.1 Overview
9.3.2 Oral: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Intravenous/ Subcutaneous
9.4.1 Overview
9.4.2 Intravenous/ Subcutaneous: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Inhalational
9.5.1 Overview
9.5.2 Inhalational: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Distribution Channel
10.1 Overview
10.2 MEA Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)
10.3 Hospital Pharmacies and Clinics
10.3.1 Overview
10.3.2 Hospital Pharmacies and Clinics: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Online Pharmacies
10.4.1 Overview
10.4.2 Online Pharmacies: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Retail Pharmacies
10.5.1 Overview
10.5.2 Retail Pharmacies: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11. MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – Country Analysis
11.1 Overview
11.1.1 Middle East & Africa: Pulmonary Arterial Hypertension Market, by Country, 2021 & 2028 (%)
11.1.1.1 UAE: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 UAE: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 UAE: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)
11.1.1.1.4 UAE: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)
11.1.1.1.5 UAE: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)
11.1.1.1.6 UAE: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.1.2 Saudi Arabia: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Saudi Arabia: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)
11.1.1.2.4 Saudi Arabia: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)
11.1.1.2.5 Saudi Arabia: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)
11.1.1.2.6 Saudi Arabia: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.1.3 South Africa: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 South Africa: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 South Africa: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)
11.1.1.3.4 South Africa: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)
11.1.1.3.5 South Africa: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)
11.1.1.3.6 South Africa: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.1.4 Rest of the MEA: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Rest of the MEA: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Rest of the MEA: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)
11.1.1.4.4 Rest of the MEA: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)
11.1.1.4.5 Rest of the MEA: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)
11.1.1.4.6 Rest of the MEA: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)
12. MEA Pulmonary Arterial Hypertension Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Johnson & Johnson
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Gilead Sciences Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Novartis AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 GSK Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Teva Pharmaceutical Industries Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Lupin Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms



List of Figures

LIST OF FIGURES
Figure 1. MEA Pulmonary Arterial Hypertension Market Segmentation
Figure 2. MEA Pulmonary Arterial Hypertension Market – By Country
Figure 3. MEA Pulmonary Arterial Hypertension Market Overview
Figure 4. Prostacyclin and Prostacyclin Analogs Segment Held Largest Share by Drugs of the MEA Pulmonary Arterial Hypertension Market
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. MEA: PEST Analysis
Figure 7. Experts Opinion
Figure 8. MEA Pulmonary Arterial Hypertension Market Impact Analysis of Drivers and Restraint
Figure 9. MEA Pulmonary Arterial Hypertension Market– Revenue Forecast and Analysis – 2020 - 2028
Figure 10. MEA Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)
Figure 11. Endothelin Receptor Antagonists (ERAs): MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Prostacyclin and Prostacyclin Analogs: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. sGC Stimulators: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pde-5 Dipsticks: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. MEA Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)
Figure 16. Branded: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Generics: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. MEA Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)
Figure 19. Oral: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Intravenous/ Subcutaneous: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Inhalational: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)
Figure 23. Hospital Pharmacies and Clinics: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Online Pharmacies: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Retail Pharmacies: MEA Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Middle East & Africa: Pulmonary Arterial Hypertension Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. UAE: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Saudi Arabia: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. South Africa: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of the Middle East and Africa: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

List of Tables

LIST OF TABLES
Table 1. MEA Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)
Table 3. UAE Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 5. UAE Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 9. Saudi Arabia Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 13. South Africa Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of the Middle East and Africa Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of the Middle East and Africa Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of the MEA Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of the MEA Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 18. Organic Developments in the MEA pulmonary arterial hypertension market
Table 19. Inorganic Developments in the MEA pulmonary arterial hypertension market
Table 20. Glossary of Terms